- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02488876
Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery
October 2, 2017 updated by: RWTH Aachen University
Non-individual Related Ongoing Collection of Blood Samples for the Compilation of a Unique Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery
The aim of this study is to collect non-individual related blood samples for the compelling of a unique database of tissue samples to understand the inflammatory responds after cardiac surgery on an on-going basis.
This includes especially protein analyses and genetic testing for certain neurotransmitters in the blood and tissues to understand disease markers related to heart disease.
The study is designed as an openly recruiting biobank with the purpose to later serve multiple study purposes.
Outcomes refer to protein analyses and genetic testing for neurotransmitters in the blood and tissues.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andreas Goetzenich, PD Dr. med.
- Phone Number: +49 241 80 35556
- Email: agoetzenich@ukaachen.de
Study Contact Backup
- Name: Christian Stoppe, PD Dr. med.
- Phone Number: +49 241 80 36575
- Email: cstoppe@ukaachen.de
Study Locations
-
-
NRW
-
Aachen, NRW, Germany, 52074
- Recruiting
- University Hospital RWTH Aachen, Department of Thoracic and Cardiovascular Surgery
-
Contact:
- Andreas Goetzenich, PD Dr. med.
- Phone Number: +49 241 80 35556
- Email: agoetzenich@ukaachen.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients scheduled for cardiac surgery
Description
Inclusion Criteria:
- Patients undergoing cardiac surgery
Exclusion Criteria:
- None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Inflammatory Cytokines
Time Frame: Perioperatively until 7 days after cardiac surgery
|
Perioperatively until 7 days after cardiac surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andreas Goetzenich, PD Dr. med., Department of Cardiothoracic Surgery
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2009
Primary Completion (ANTICIPATED)
December 1, 2099
Study Completion (ANTICIPATED)
December 1, 2099
Study Registration Dates
First Submitted
May 4, 2015
First Submitted That Met QC Criteria
July 1, 2015
First Posted (ESTIMATE)
July 2, 2015
Study Record Updates
Last Update Posted (ACTUAL)
October 3, 2017
Last Update Submitted That Met QC Criteria
October 2, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK 151/09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Kathirvel SubramaniamUniversity of Maryland, Baltimore; CSL BehringRecruitingHeart Failure,Congestive | Heart Disease End StageUnited States
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Yonsei UniversityCompletedMitral Valvular Heart Disease
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
University College, LondonBritish Heart Foundation; Horizon 2020 - European CommissionRecruitingValvular Heart DiseaseUnited Kingdom